搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Desulforudis audaxviator S-adenosylmethionine synthase (metK) CSB-YP534170DJM
CSB-EP534170DJM
CSB-BP534170DJM
CSB-MP534170DJM
CSB-EP534170DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator ATP synthase epsilon chain (atpC) CSB-YP534171DJM
CSB-EP534171DJM
CSB-BP534171DJM
CSB-MP534171DJM
CSB-EP534171DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator UPF0059 membrane protein Daud_2150 (Daud_2150), partial CSB-YP534172DJM1
CSB-EP534172DJM1
CSB-BP534172DJM1
CSB-MP534172DJM1
CSB-EP534172DJM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Arginine--tRNA ligase (argS), partial CSB-YP534173DJM
CSB-EP534173DJM
CSB-BP534173DJM
CSB-MP534173DJM
CSB-EP534173DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S15 (rpsO) CSB-YP534174FNA
CSB-EP534174FNA
CSB-BP534174FNA
CSB-MP534174FNA
CSB-EP534174FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP534175FNA
CSB-EP534175FNA
CSB-BP534175FNA
CSB-MP534175FNA
CSB-EP534175FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Putative membrane protein insertion efficiency factor (SPH_1989) CSB-YP534176FNA
CSB-EP534176FNA
CSB-BP534176FNA
CSB-MP534176FNA
CSB-EP534176FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UPF0154 protein SPH_1998 (SPH_1998), partial CSB-YP534177FNA
CSB-EP534177FNA
CSB-BP534177FNA
CSB-MP534177FNA
CSB-EP534177FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Probable transcriptional regulatory protein SPH_2064 (SPH_2064) CSB-YP534178FNA
CSB-EP534178FNA
CSB-BP534178FNA
CSB-MP534178FNA
CSB-EP534178FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Putative Holliday junction resolvase (SPH_0310) CSB-YP534179FNA
CSB-EP534179FNA
CSB-BP534179FNA
CSB-MP534179FNA
CSB-EP534179FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L22 (rplV) CSB-YP534180FNA
CSB-EP534180FNA
CSB-BP534180FNA
CSB-MP534180FNA
CSB-EP534180FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L16 (rplP) CSB-YP534181FNA
CSB-EP534181FNA
CSB-BP534181FNA
CSB-MP534181FNA
CSB-EP534181FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S14 (rpsN) CSB-YP534182FNA
CSB-EP534182FNA
CSB-BP534182FNA
CSB-MP534182FNA
CSB-EP534182FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L6 (rplF) CSB-YP534183FNA
CSB-EP534183FNA
CSB-BP534183FNA
CSB-MP534183FNA
CSB-EP534183FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L17 (rplQ) CSB-YP534184FNA
CSB-EP534184FNA
CSB-BP534184FNA
CSB-MP534184FNA
CSB-EP534184FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L34 (rpmH) CSB-YP534185FNA
CSB-EP534185FNA
CSB-BP534185FNA
CSB-MP534185FNA
CSB-EP534185FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S12 (rpsL) CSB-YP534186FNA
CSB-EP534186FNA
CSB-BP534186FNA
CSB-MP534186FNA
CSB-EP534186FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S9 (rpsI) CSB-YP534187FNA
CSB-EP534187FNA
CSB-BP534187FNA
CSB-MP534187FNA
CSB-EP534187FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae S-ribosylhomocysteine lyase (luxS) CSB-YP534188FNA
CSB-EP534188FNA
CSB-BP534188FNA
CSB-MP534188FNA
CSB-EP534188FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Glutamate--tRNA ligase (gltX) CSB-YP534189FNA
CSB-EP534189FNA
CSB-BP534189FNA
CSB-MP534189FNA
CSB-EP534189FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>